Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-25 @ 7:26 PM
Study NCT ID:
NCT01324232
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2011-03-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Sponsor:
Avanir Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-23
First Submit QC Date:
None
Study First Post Date:
2011-03-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-31
Results First Submit QC Date:
None
Results First Post Date:
2021-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-01-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-22
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL